Literature DB >> 31432503

Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation.

Hyunsoo Kim1, Matthew C Walsh1, Jiyeon Yu1, Paul Laskoski1, Kei Takigawa1, Noriko Takegahara1, Yongwon Choi1.   

Abstract

Purinergic signaling plays important roles in bone. P2X5, a member of ligand-gated ion channel receptors, has been demonstrated to regulate osteoclast maturation. However, the molecular mechanism of P2X5-mediated osteoclast regulation remains unclear. Here, we identified methylosome protein 50 (MEP50), a critical cofactor of the protein arginine methyltransferase 5 (PRMT5), as a P2X5-associating molecule. RNAi-mediated knockdown of MEP50 results in decreased formation of mature osteoclasts. MEP50 associates with P2X5, and this association requires the C-terminal intracellular region of P2X5. Additionally, impaired maturation of P2X5-deficient osteoclasts could be restored by transduction of full-length P2X5, but not a C-terminal deletion mutant of P2X5. These results indicate that P2X5 associates with MEP50 and suggest a link between the PRMT5 complex and P2X5 signaling in osteoclast maturation.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  MEP50; P2X5; PRMT5; RNAi-mediated knockdown; maturation; methylosome; osteoclast

Mesh:

Substances:

Year:  2019        PMID: 31432503      PMCID: PMC6957751          DOI: 10.1002/1873-3468.13581

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss.

Authors:  Niki M Moutsopoulos; Joanne Konkel; Mojgan Sarmadi; Mehmet A Eskan; Teresa Wild; Nicolas Dutzan; Loreto Abusleme; Camille Zenobia; Kavita B Hosur; Toshiharu Abe; Gulbu Uzel; Wanjun Chen; Triantafyllos Chavakis; Steven M Holland; George Hajishengallis
Journal:  Sci Transl Med       Date:  2014-03-26       Impact factor: 17.956

Review 3.  Arginine methylation an emerging regulator of protein function.

Authors:  Mark T Bedford; Stéphane Richard
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  Cryopyrin activates the inflammasome in response to toxins and ATP.

Authors:  Sanjeev Mariathasan; David S Weiss; Kim Newton; Jacqueline McBride; Karen O'Rourke; Meron Roose-Girma; Wyne P Lee; Yvette Weinrauch; Denise M Monack; Vishva M Dixit
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

5.  Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.

Authors:  Yonghui Dong; Chao Song; Yuting Wang; Zuowei Lei; Fei Xu; Hanfeng Guan; Anmin Chen; Feng Li
Journal:  Cell Signal       Date:  2017-03-14       Impact factor: 4.315

6.  RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice.

Authors:  Sergio Vaira; Muhammad Alhawagri; Imani Anwisye; Hideki Kitaura; Roberta Faccio; Deborah Veis Novack
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice.

Authors:  A Gartland; K A Buckley; R A Hipskind; M J Perry; J H Tobias; G Buell; I Chessell; W B Bowler; J A Gallagher
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2003       Impact factor: 1.807

8.  Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.

Authors:  Simona Taverna; Marzia Pucci; Marco Giallombardo; Maria Antonietta Di Bella; Mariacarmela Santarpia; Pablo Reclusa; Ignacio Gil-Bazo; Christian Rolfo; Riccardo Alessandro
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

9.  Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.

Authors:  Meng-Chiao Ho; Carola Wilczek; Jeffrey B Bonanno; Li Xing; Janina Seznec; Tsutomu Matsui; Lester G Carter; Takashi Onikubo; P Rajesh Kumar; Man K Chan; Michael Brenowitz; R Holland Cheng; Ulf Reimer; Steven C Almo; David Shechter
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis.

Authors:  Hyunsoo Kim; Tetsuhiro Kajikawa; Matthew C Walsh; Noriko Takegahara; Yun Hee Jeong; George Hajishengallis; Yongwon Choi
Journal:  BMB Rep       Date:  2018-09       Impact factor: 4.778

View more
  5 in total

1.  Exogenous adenosine activates A2A adenosine receptor to inhibit RANKL-induced osteoclastogenesis via AP-1 pathway to facilitate bone repair.

Authors:  Xin Cheng; Chengcheng Yin; Yongqiang Deng; Zubing Li
Journal:  Mol Biol Rep       Date:  2021-11-30       Impact factor: 2.316

Review 2.  Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.

Authors:  Brian F King
Journal:  Purinergic Signal       Date:  2022-10-24       Impact factor: 3.950

Review 3.  Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.

Authors:  Laura Gambari; Francesco Grassi; Livia Roseti; Brunella Grigolo; Giovanna Desando
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

4.  Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation.

Authors:  Hyunsoo Kim; Noriko Takegahara; Yongwon Choi
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

Review 5.  Osteoclast Multinucleation: Review of Current Literature.

Authors:  Joe Kodama; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.